EDGAR Filing Documents for 0001171843-17-005932

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001171843-17-005932

Filing Date

2017-10-05

Accepted

2017-10-04 19:00:29

Documents

Period of Report

2017-10-04

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 6-K	f6k_100417.htm	6-K	10813
2	EXHIBIT 99.1	exh_991.htm	EX-99.1	14576
3	GRAPHIC	image_004.jpg	GRAPHIC	4316
	Complete submission text file	0001171843-17-005932.txt		32478

Mailing Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3

Business Address 545 PROMENADE DU CENTROPOLIS, SUITE 100 LAVAL A8 H7T 0A3 (450) 687-2262

Acasti Pharma Inc. (Filer) CIK: 0001444192 (see all company filings)